Harvard Apparatus Inc. Acquires The Biochrom Business Of Pharmacia & Upjohn Inc. Harvard Apparatus, Inc. (HAI) of Holliston, MA. announces the acquisition of the Biochrom Business of Pharmacia & Upjohn and a distribution partnership with Amersham Pharmacia Biotech for the continued distribution of
Harvard Apparatus Ltd. Acquires Clark Electromedical Instruments Harvard Apparatus, Inc. (HAI) of Holliston, Massachusetts announces the acquisition of Clark Electromedical Instruments by Harvard Apparatus Ltd. our UK subsidiary located in Edenbridge, England.
Harvard Apparatus, Inc. Acquires Hugo Sachs Elektronik Harvard Apparatus, Inc. of Holliston, Massachusetts USA, announces the acquisition of Hugo Sachs Elektronik of March - Hugstetten, Germany. Hugo Sachs, founded in 1960, is the market leader in the design, manufacture and distribution of
Harvard Apparatus And Trega Biosciences Announce Harvard's Acquisition Of The Diffusion Chamber Systems Product Line From Trega Biosciences San Diego, CA and Holliston, MA -- December 3rd, 1999 -- Trega Biosciences, Inc (NASDAQ:TRGA) of San Diego, CA, and Harvard Apparatus, Inc.
Harvard Apparatus Completes The Aquisition Of Amika Corporation Harvard Apparatus Inc. (HAI) of Holliston, MA, announced today that it has completed the acquisition of substantially all the assets of AmiKa Corp., whose products are at the heart of much of today's gene and protein discovery.
Harvard Bioscience Completes Acquisition of Mitoscan Toxicology Testing Business HOLLISTON, Mass., Dec. 28 /PRNewswire/ -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced the acquisition of the high throughput toxicology screening business of Mitoscan Corporation of Madison, Wisconsin.
Harvard Bioscience Announces Exercise of Overallotment HOLLISTON, Mass., Jan. 9 /PRNewswire/ -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that the underwriters of its initial public offering have exercised in full their overallotment option to purchase an additional 937,500 shares.
Harvard Bioscience, Inc. Invites You to Join Its Fourth Quarter and Year Ended 2000 Conference Call on the Web HOLLISTON, Mass., Feb. 14 /PRNewswire/ -- Harvard Bioscience, Inc. (Nasdaq: HBIO) You are invited to listen to our fourth quarter and year ended 2000 conference call.
Harvard Bioscience, Inc. Reports Financial Results For Fourth Quarter And Year Ended 2000 HOLLISTON, Mass., Feb. 22 /PRNewswire/ -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today reported record revenues for the year and the quarter ended December 31, 2000.
Harvard Bioscience, Inc. Launches New ADMET Product HOLLISTON, Mass., Feb. 27 /PRNewswire/ -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced the introduction of ScanTox , a drug safety evaluation tool that provides a more sensitive means of lead optimization than currently